AUTHOR=Sfikakis Petros P. , Verrou Kleio-Maria , Ampatziadis-Michailidis Giannis , Tsitsilonis Ourania , Paraskevis Dimitrios , Kastritis Efstathios , Lianidou Evi , Moutsatsou Paraskevi , Terpos Evangelos , Trougakos Ioannis , Chini Vasiliki , Manoloukos Menelaos , Moulos Panagiotis , Pavlopoulos Georgios A. , Kollias George , Hatzis Pantelis , Dimopoulos Meletios A. TITLE=Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection JOURNAL=Frontiers in Immunology VOLUME=12 YEAR=2021 URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.746203 DOI=10.3389/fimmu.2021.746203 ISSN=1664-3224 ABSTRACT=
The reasons behind the clinical variability of SARS-CoV-2 infection, ranging from asymptomatic infection to lethal disease, are still unclear. We performed genome-wide transcriptional whole-blood RNA sequencing, bioinformatics analysis and PCR validation to test the hypothesis that immune response-related gene signatures reflecting baseline may differ between healthy individuals, with an equally robust antibody response, who experienced an entirely asymptomatic (n=17)